MOG-IgG in Multiple Sclerosis

(3:35)

Analysis of the diagnostic utility of cerebrospinal fluid MOG-IgG

(5:42)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

(13:27)

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and NMOSDs

(1:51)

2018 RNDS — MOG Antibody-Associated Disease

(23:37)

2024 RNDS | Clinical Analysis of Children Presenting with ADEM with or without MOG-IgG

(21:11)

NSGR-Pediatric Neuroimmunology – A Case Based Approach

(59:30)

MOGAD (Myelin Oligodendrocyte Glycoprotein Associated Disease) Explained by Neurologist

(23:31)

MOG-IgA characterizes a subgroup of patients with central nervous system demyelination

(4:40)

Proposed criteria for the diagnosis of MOGAD

(1:46)

Optic Neuritis: It's not just multiple sclerosis anymore - John Chen, MD, PhD

(59:16)

MOG and Neuromyelitis Optica

(7:27)

Dr. Mitzi Williams: NMOSD vs. Anti-MOG Syndrome

(51)

Myelin Oligodendrocyte Glycoprotein (MOG)

(4:11)

Clinical Pearls in Autoimmune Encephalopathy - Eoin Flanagan, M.D.

(38:58)

NMO MOG Treatment Approach

(3:24)

Current MOGAD criteria and the role of MRI in diagnosis

(1:4)

Optic Neuritis in the Era of Biomarkers

(17:12)

2024 MOGAD Together | Community Q\u0026A

(58:30)

808. MOG Antibody Disease: Adult and Pediatric Presentations

(54:7)